Your search returned the following 10 documents:

10. Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced Patients
    Luke C. Swenson, Theresa Mo, Winnie W. Y. Dong, Xiaoyin Zhong, Conan K. Woods, Mark A. Jensen, Alexander Thielen, Douglass Chapman, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P. Richard Harrigan
    The Journal of Infectious Diseases 203 (3): 237-245, 2011
    
9. Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc.
   Luke C Swenson, Theresa Mo, Winnie WY Dong, Xiaoyin Zhong, Conan K Woods, Alexander Thielen, Mark A Jensen, David JHF Knapp, Douglass Chapman, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P Richard Harrigan
   Clinical Infectious Diseases 53 (7): 732-742, 2011
   
8. Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially
   Alexander Thielen, Thomas Lengauer, Luke C Swenson, Winnie W.Y. Dong, Rachel A McGovern, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P Richard Harrigan
   Antiviral Therapy 16 (3): 319-328, 2011
   
7. Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA
   Luke C. Swenson, Andrew Moores, Andrew J. Low, Alexander Thielen, Winnie Dong, Conan Woods, Mark A. Jensen, Brian Wynhoven, Dennison Chan, Christopher Glascock, and P. Richard Harrigan
   Journal of Acquired Immune Deficiency Syndromes 54 (5): 506-510, 2010
   
6. Mutations within GP41 are correlated with coreceptor tropism but do not substantially improve coreceptor usage prediction
   Alexander Thielen, Thomas Lengauer, P Richard Harrigan, Luke Swenson, Winnie WY Dong, Rachel A McGovern, Marilyn Lewis, Ian James, Jayvant Heera, and Hernan Valdez
   In: Reviews in Antiviral Therapy & Infectious Diseases, Sorrento, Italy, 2010, 47-47
   
5. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies
   Rachel A McGovern, Alexander Thielen, Theresa Mo, Winnie Dong, Conan K Woods, Douglass Chapman, Marilyn Lewis, Ian James, Jayvant Heera, Hernan Valdez, and P Richard Harrigan
   AIDS 24 (16): 2517-2525, 2010
   
4. Screening for HIV tropism using population-based V3 genotypic analysis: a retrospective outcome analysis using stored plasma screening samples from MOTIVATE-1
   P Richard Harrigan, Rachel McGovern, Winnie Dong, Alexander Thielen, Mark Jensen, Theresa Mo, Douglas Chapman, Marilyn Lewis, Ian James, and Hernan Valdez
   In: Abstracts presented at the XVIII International HIV Drug Resistance Workshop : Basic Principles & Clinical Implications, Fort Myers, USA, 2009, A17-A17, paper no. Abstract 15.
   
3. Improved detection of X4 virus by V3 genotyping: application to plasma RNA and proviral DNA
   Andrew Moores, Alexander Thielen, Winnie Dong, Andrew J. Low, Conan Woods, Mark Jensen, Brian Wynhoven, Dennison Chan, Christopher Glascock, and P Richard Harrigan
   In: Antiviral Therapy, Sitges, Spain, 2008, A99 p.
   
2. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates
   Andrew J. Low, Winnie Dong, Dennison Chan, Tobias Sing, Ronald Swanstrom, Mark Jensen, Satish Pillai, Benjamin Good, and P. Richard Harrigan
   AIDS 21 (14): F19-F26, 2007
   
1. Determining human immunodeficiency virus coreceptor use in a clinical setting: Degree of correlation between two phenotypic assays and a bioinformatic model
   Katharina Skrabal, Andrew J. Low, Winnie Dong, Tobias Sing, Peter K. Cheung, Fabrizio Mammano, and P. Richard Harrigan
   Journal of Clinical Microbiology 45 (2): 279-284, 2007